-
1
المؤلفون: J. Mazereeuw‐Hautier, A. Vahlquist, H. Traupe, A. Bygum, C. Amaro, M. Aldwin, A. Audouze, C. Bodemer, E. Bourrat, A. Diociaiuti, M. Dolenc‐Voljc, I. Dreyfus, M. El Hachem, J. Fischer, A. Gånemo, C. Gouveia, R. Gruber, S. Hadj‐Rabia, D. Hohl, N. Jonca, K. Ezzedine, D. Maier, R. Malhotra, M. Rodriguez, H. Ott, D.G. Paige, A. Pietrzak, F. Poot, M. Schmuth, J.C. Sitek, P. Steijlen, G. Wehr, M. Moreen, E.A. O'Toole, V. Oji, A. Hernandez‐Martin
المساهمون: MUMC+: MA Dermatologie (3), Dermatologie, MUMC+: MA AIOS Dermatologie (9), MUMC+: MA Dermatologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, CHU Toulouse [Toulouse], Uppsala University, Westfälische Wilhelms-Universität Münster = University of Münster (WWU), Odense University Hospital (OUH), Hospital de Santa Maria [Lisboa], Ichthyosis Support Group, PO Box 1242, Yateley, GU47 7FL, U.K., Association Ichtyose France, Bellerive sur Allier, France., CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hopital Saint-Louis [AP-HP] (AP-HP), Bambino Gesù Children’s Hospital [Rome, Italy], University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), University of Freiburg [Freiburg], Skane University Hospital [Malmo], Lund University [Lund], Bern University Hospital [Berne] (Inselspital), University of Innsbruck, Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Unité différenciation épidermique et auto-immunité rhumatoïde (UDEAR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidemiology in Dermatology and Evaluation in Therapeutics (EpiDermE), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Iuliu Hatieganu University of Medicine & Pharmacy, Queen Victoria Hospital NHS Foundation Trust, Hospital Universitario Son Espases, Children's Hospital 'Auf der Bult', Royal Free Hospital [London, UK], Medical University of Lublin, Oslo University Hospital [Oslo], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], University Hospitals Leuven [Leuven], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Queen Mary University of London (QMUL), University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), Hospital Infantil Universitario Niño Jesús (HIUNJ)
المصدر: Mazereeuw-Hautier, J, Vahlquist, A, Traupe, H, Bygum, A, Amaro, C, Aldwin, M, Audouze, A, Bodemer, C, Bourrat, E, Diociaiuti, A, Dolenc-Voljc, M, Dreyfus, I, El Hachem, M, Fischer, J, Gånemo, A, Gouveia, C, Gruber, R, Hadj-Rabia, S, Hohl, D, Jonca, N, Ezzedine, K, Maier, D, Malhotra, R, Rodriguez, M, Ott, H, Paige, D G, Pietrzak, A, Poot, F, Schmuth, M, Sitek, J C, Steijlen, P, Wehr, G, Moreen, M, O'Toole, E A, Oji, V & Hernandez-Martin, A 2019, ' Management of congenital ichthyoses : European guidelines of care, part one ', British Journal of Dermatology, vol. 180, no. 2, pp. 272-281 . https://doi.org/10.1111/bjd.17203
British Journal of Dermatology, 180(2), 272-281. Wiley
British Journal of Dermatology
British Journal of Dermatology, Wiley, 2019, 180 (2), pp.272-281. ⟨10.1111/bjd.17203⟩مصطلحات موضوعية: VITAMIN-D DEFICIENCY, PREMATURE EPIPHYSEAL CLOSURE, Consensus, MESH: Dermatology / methods, Administration, Topical, MESH: Social Support, ORAL RETINOID THERAPY, Administration, Oral, Genetic Counseling, Dermatology, MESH: Ichthyosiform Erythroderma, Congenital / psychology, 030207 dermatology & venereal diseases, 03 medical and health sciences, DOUBLE-BLIND, BONE CHANGES, 0302 clinical medicine, Behavior Therapy, QUALITY-OF-LIFE, MESH: Dermatologic Agents / therapeutic use, EPIDERMOLYTIC HYPERKERATOSIS, Humans, MESH: Consensus, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, KID SYNDROME, MESH: Humans, MESH: Behavior Therapy / standards, MESH: Behavior Therapy / methods, MESH: Ichthyosiform Erythroderma, Congenital / diagnosis, Social Support, MESH: Quality of Life, Ichthyosiform Erythroderma, Congenital, MESH: Dermatology / standards, MESH: Administration, Topical, Europe, HARLEQUIN ICHTHYOSIS, MESH: Genetic Counseling / standards, MESH: Ichthyosiform Erythroderma, Congenital / therapy, MESH: Administration, Oral, Quality of Life, [SDV.IMM]Life Sciences [q-bio]/Immunology, LAMELLAR ICHTHYOSIS, Dermatologic Agents, MESH: Europe, MESH: Systematic Reviews as Topic, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, Systematic Reviews as Topic
وصف الملف: application/pdf
-
2
المؤلفون: Christopher D. Pilcher, Omar Sued, Christophe Fraser, Sarah Fidler, Myron S. Cohen, Marco Vitoria, Jintanat Ananworanich, Joseph D. Tucker, Cheryl Johnson, Sarah E. Rutstein, Meg Doherty, Asier Sáez-Cirión, Eduard J. Sanders
المساهمون: University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine (HJM), Imperial College London, Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), London School of Hygiene and Tropical Medicine (LSHTM), University of Amsterdam [Amsterdam] (UvA), Kenya Medical Research Institute (KEMRI), Nuffield Department of Medicine [Oxford, UK] (Big Data Institute), University of Oxford, Fundación Huésped [Buenos Aires], HIV, Inflammation et persistance - HIV, Inflammation and Persistence, Institut Pasteur [Paris] (IP), University of California [San Francisco] (UC San Francisco), University of California (UC), EJS is supported by Wellcome Trust and the KWTRP at the Centre for Geographical Medicine Research‐Kilifi (supported by core funding from the Wellcome Trust (#203077/Z/16/Z)), with support from the International AIDS Vaccine Initiative. JDT is supported by NIAID R21AI20549. SF is supported by NIHR BRC. SER was supported by National Institutes of Health [R01 AI114320], [F30 MH098731] and [T32 GM008719]., University of Oxford [Oxford], HIV, Inflammation et persistance, Institut Pasteur [Paris], University of California [San Francisco] (UCSF), University of California, Imperial College Healthcare NHS Trust- BRC Funding, MRC DCS, Medical Research Council (MRC), Merck Sharp & Dohme Ltd.
المصدر: Journal of the International AIDS Society
Journal of the International AIDS Society, 2017, 20 (1), pp.21579. ⟨10.7448/IAS.20.1.21579⟩
Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2017, 20 (1), pp.21579. ⟨10.7448/IAS.20.1.21579⟩مصطلحات موضوعية: 0301 basic medicine, T-CELL COUNTS, [SDV]Life Sciences [q-bio], Human immunodeficiency virus (HIV), HIV Infections, Review Article, medicine.disease_cause, COST-EFFECTIVENESS, acute HIV infection, Pre-exposure prophylaxis, 0302 clinical medicine, MESH: Early Diagnosis, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Behavior Therapy, diagnostics, 030212 general & internal medicine, Prospective Studies, guidelines, low- and middle-income countries, Prospective cohort study, SUB-SAHARAN AFRICA, ADULTS SEEKING CARE, Framingham Risk Score, Transmission (medicine), MESH: Behavior Therapy, MESH: HIV Infections, 3. Good health, MESH: Point-of-Care Systems, Infectious Diseases, Public Health, AG/AB COMBO TEST, VIRAL-LOAD, MESH: Public Health, Viral load, Life Sciences & Biomedicine, early HIV, medicine.medical_specialty, Point-of-Care Systems, 030106 microbiology, Immunology, antiretroviral therapy, primary HIV, UNITED-STATES, 03 medical and health sciences, medicine, Humans, Intensive care medicine, Science & Technology, MESH: Humans, business.industry, Public health, Public Health, Environmental and Occupational Health, 1199 Other Medical And Health Sciences, MESH: Prospective Studies, respiratory tract diseases, Early Diagnosis, EARLY ANTIRETROVIRAL THERAPY, Pre-Exposure Prophylaxis, Implementation research, business, SEXUALLY-TRANSMITTED INFECTION, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, PREEXPOSURE PROPHYLAXIS, MESH: Pre-Exposure Prophylaxis
وصف الملف: application/pdf
-
3
المساهمون: Laboratoire Inter-universitaire de Psychologie : Personnalité, Cognition, Changement Social (LIP-PC2S), Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry]), Department of Psychology, University of Waterloo [Waterloo], Laboratoire de Psychologie et NeuroCognition (LPNC), Centre National de la Recherche Scientifique (CNRS)-Université Pierre Mendès France - Grenoble 2 (UPMF)-Université Joseph Fourier - Grenoble 1 (UJF)-Université Savoie Mont Blanc (USMB [Université de Savoie] [Université de Chambéry])
المصدر: Behaviour Research and Therapy
Behaviour Research and Therapy, Elsevier, 2012, 50 (7-8), pp.449-56. ⟨10.1016/j.brat.2012.04.003⟩مصطلحات موضوعية: MESH: Psychiatric Status Rating Scales, Obsessive-Compulsive Disorder, 050103 clinical psychology, MESH: Self Report, Thinking, 0302 clinical medicine, Behavior Therapy, Surveys and Questionnaires, MESH: Thinking, MESH: Middle Aged, 05 social sciences, Eating pathology, MESH: Behavior Therapy, Cognition, Middle Aged, MESH: Case-Control Studies, Psychiatry and Mental health, Clinical Psychology, Distress, Eating disorders, MESH: Young Adult, Trait, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Female, MESH: Eating Disorders, Psychology, Adult, medicine.medical_specialty, Adolescent, Experimental and Cognitive Psychology, Feeding and Eating Disorders, Young Adult, 03 medical and health sciences, Cognitive distortion, MESH: Analysis of Variance, Body Image, medicine, Humans, 0501 psychology and cognitive sciences, Psychiatry, MESH: Body Image, Thought shape fusion, MESH: Adolescent, MESH: Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Analysis of Variance, MESH: Humans, MESH: Questionnaires, MESH: Adult, medicine.disease, 030227 psychiatry, MESH: Cognition Disorders, Case-Control Studies, Self Report, Cognition Disorders, MESH: Female
-
4
المؤلفون: Michel de Lorgeril
المساهمون: Physiologie cardio-Respiratoire Expérimentale Théorique et Appliquée (TIMC-IMAG-PRETA), Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications, Grenoble - UMR 5525 (TIMC-IMAG), VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)
المصدر: BMC Medicine
BMC Medicine, BioMed Central, 2012, 10, pp.139. ⟨10.1186/1741-7015-10-139⟩
BMC Medicine, Vol 10, Iss 1, p 139 (2012)مصطلحات موضوعية: obesity, lcsh:Medicine, 030204 cardiovascular system & hematology, Overweight, 0302 clinical medicine, Behavior Therapy, MESH: Metabolic Syndrome X, insulin resistance, 030212 general & internal medicine, triglycerides, Medicine(all), Metabolic Syndrome, diabetes, MESH: Behavior Therapy, MESH: Life Style, General Medicine, 3. Good health, Treatment Outcome, Meta-analysis, medicine.symptom, Research Article, medicine.medical_specialty, lifestyle, hypertension, Physical exercise, high-density lipoprotein, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Diabetes mellitus, medicine, overweight, Humans, Intensive care medicine, Adverse effect, Exercise, Life Style, MESH: Humans, business.industry, lcsh:R, Type 2 Diabetes Mellitus, medicine.disease, Obesity, meta-analysis, Endocrinology, randomized controlled trial, Systematic review, Commentary, lifestyle modification, Metabolic syndrome, business, Diet Therapy
-
5
المؤلفون: Krystal L. Moorman, Heather P. Whitley
المصدر: Pharmacy Practice (Granada) v.5 n.2 2007
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice (Granada), Volume: 5, Issue: 2, Pages: 51-58, Published: JUN 2007
Pharmacy Practiceمصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Alternative medicine, Review, chemistry.chemical_compound, Acquired immunodeficiency syndrome (AIDS), Behavior Therapy, Tobacco, medicine, mesh:Behavior Therapy, Varenicline, Psychiatry, Tratamiento comportamental, Nicotine replacement, Bupropion, business.industry, Bupropion sr, medicine.disease, mesh:Smoking Cessation, mesh:Varenicline, Clinical trial, chemistry, Vareniclina Tabaco, Cesación tabáquica, mesh:Tobacco, Smoking cessation, Smoking Cessation, business, medicine.drug
وصف الملف: text/html
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e120978d2eb97233a00b94d50cd728b
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2007000200001 -
6
المؤلفون: Jacques Sizun, Vincent Morin, Emmanuel Oger, Céline Catelin, Sylvie Tordjman
المساهمون: CHRU de Brest - Département de Pédiatrie (CHU BREST Pédiatrie), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Fondation Vallée, Université Paris-Sud - Paris 11 (UP11), Département de Statistique, Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Journal of Pain
Journal of Pain, Elsevier, 2005, 6 (12), pp.791-7. ⟨10.1016/j.jpain.2005.07.010⟩مصطلحات موضوعية: Male, Aging, Hydrocortisone, Oxygenation index, MESH: Pain Measurement, law.invention, 0302 clinical medicine, Randomized controlled trial, Behavior Therapy, Heart Rate, law, Medicine, MESH: Nursing, MESH: Aging, 030212 general & internal medicine, MESH: Oxygen Consumption, MESH: Heart Rate, Pain Measurement, Oxygen saturation (medicine), MESH: Treatment Outcome, Cross-Over Studies, MESH: Infant, Newborn, Age Factors, MESH: Pain Threshold, MESH: Behavior Therapy, Brain, Gestational age, MESH: Stress, Psychological, Environment, Controlled, MESH: Hydrocortisone, 3. Good health, Treatment Outcome, Neurology, Anesthesia, Female, MESH: Pain, Pain Threshold, Pain, Nursing, MESH: Cross-Over Studies, MESH: Environment, Controlled, 03 medical and health sciences, MESH: Brain, Oxygen Consumption, 030225 pediatrics, Heart rate, Humans, Behavioral interventions, MESH: Age Factors, MESH: Humans, business.industry, Infant, Newborn, Oxygenation, MESH: Neonatology, Crossover study, MESH: Male, Anesthesiology and Pain Medicine, Neurology (clinical), Neonatology, business, MESH: Female, Stress, Psychological, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
-
7
-
8
Find this article in full text from Springer Verlag.